TipRanks
Silexion Therapeutics (SLXN)
NASDAQ:SLXN
US Market
SLXN
Silexion Therapeutics
RESEARCH TOOLSreports
Want to see SLXN full AI Analyst Report?

Silexion Therapeutics (SLXN) Ratios

244 Followers

Silexion Therapeutics Ratios

SLXN's free cash flow for Q2 2026 was $0.00. For the 2026 fiscal year, SLXN's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.94 2.41 0.64 2.27 5.49
Quick Ratio
 0.94 2.41 0.64 2.27 5.49
Cash Ratio
 0.56 2.17 0.34 2.09 5.13
Solvency Ratio
 -3.32 -2.58 -2.40 -0.28 -0.19
Operating Cash Flow Ratio
 -3.13 -3.92 -2.38 -2.06 -2.07
Short-Term Operating Cash Flow Coverage
 -12.62 -59.45 -8.36 0.00 0.00
Net Current Asset Value
$ -461.00K$ 2.02M$ -4.60M$ -12.33M$ -7.57M
Leverage Ratios
Debt-to-Assets Ratio
 0.33 0.06 1.57 0.03 0.03
Debt-to-Equity Ratio
 32.05 0.18 -1.13 -0.01 -0.03
Debt-to-Capital Ratio
 0.97 0.15 8.95 -0.01 -0.03
Long-Term Debt-to-Capital Ratio
 0.00 0.10 -2.88 0.00 0.00
Financial Leverage Ratio
 96.50 2.77 -0.72 -0.34 -0.88
Debt Service Coverage Ratio
 -14.20 -60.95 -15.61 -518.67 -45.02
Interest Coverage Ratio
 1.52K 894.77 -241.75 -520.11 -45.41
Debt to Market Cap
 8.84 0.18 0.02 0.00 0.00
Interest Debt Per Share
 2.06 3.62 7.28 0.16 0.02
Net Debt to EBITDA
 0.06 0.46 -0.20 0.95 2.10
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.03%99.60%97.36%92.81%
EBT Per EBIT
-152.76%-102.38%131.33%108.44%89.74%
Return on Assets (ROA)
-328.73%-165.10%-574.33%-94.03%-34.45%
Return on Equity (ROE)
-563.11%-457.63%412.21%31.93%30.15%
Return on Capital Employed (ROCE)
3384.07%260.98%1904.70%-152.97%-49.98%
Return on Invested Capital (ROIC)
628.40%250.74%-2504.18%-147.57%-49.25%
Return on Tangible Assets
-328.73%-165.10%-574.33%-94.03%-34.45%
Earnings Yield
-7634.17%-466.65%-8.74%-1.68%-0.07%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 <0.01 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 -47.86K 0.00 0.00 0.00 0.00
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 47.86K 0.00 0.00 0.00 0.00
Operating Cycle
 0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -18.08 -81.38 -13.46 -4.05 -0.20
Free Cash Flow Per Share
 -18.09 -81.44 -13.49 -4.06 -0.20
CapEx Per Share
 <0.01 0.07 0.04 0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
 -6.21K -1.20K -381.64 -377.42 -83.38
Capital Expenditure Coverage Ratio
 -6.21K -1.20K -381.64 -377.42 -83.38
Operating Cash Flow Coverage Ratio
 -8.82 -23.12 -1.87 -26.49 -12.31
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-11154.48%-424.19%-4.48%-1.54%-0.08%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 >-0.01 -0.21 -11.42 -59.51 -1.37K
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 4.16 0.98 -47.15 -19.00 -412.90
Price-to-Free Cash Flow (P/FCF) Ratio
 >-0.01 -0.24 -22.34 -64.77 -1.30K
Price-to-Operating Cash Flow Ratio
 -0.01 -0.24 -22.40 -64.94 -1.32K
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 <0.01 0.28 <0.01 7.77
Enterprise Value Multiple
 0.05 0.25 -11.62 -62.49 -1.16K
Enterprise Value
 -707.55K -2.97M 191.39M 289.69M 4.40B
EV to EBITDA
 0.05 0.25 -11.62 -62.49 -1.16K
EV to Sales
 0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 0.06 0.27 -22.74 -63.80 -1.30K
EV to Operating Cash Flow
 0.06 0.27 -22.80 -63.96 -1.32K
Tangible Book Value Per Share
 0.06 19.58 -6.39 -10.79 -0.42
Shareholders’ Equity Per Share
 0.06 19.58 -6.39 -13.85 -0.64
Tax and Other Ratios
Effective Tax Rate
 0.00 >-0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
 0.00 0.00 0.00 0.00 0.00
Net Income Per Share
 -20.31 -89.60 -26.36 -4.42 -0.19
Tax Burden
 1.00 1.00 1.00 0.97 0.93
Interest Burden
 0.99 1.00 1.00 1.08 0.90
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.89 0.91 0.51 0.89 0.96
Currency in USD